<body><script type="text/javascript"> function setAttributeOnload(object, attribute, val) { if(window.addEventListener) { window.addEventListener('load', function(){ object[attribute] = val; }, false); } else { window.attachEvent('onload', function(){ object[attribute] = val; }); } } </script> <div id="navbar-iframe-container"></div> <script type="text/javascript" src="https://apis.google.com/js/platform.js"></script> <script type="text/javascript"> gapi.load("gapi.iframes:gapi.iframes.style.bubble", function() { if (gapi.iframes && gapi.iframes.getContext) { gapi.iframes.getContext().openChild({ url: 'https://www.blogger.com/navbar/5621345630369022014?origin\x3dhttp://cderwn.blogspot.com', where: document.getElementById("navbar-iframe-container"), id: "navbar-iframe" }); } }); </script>

Drug Evaluation & Research

CDERNEW-TEXT 9/6/2007


Thursday, September 6, 2007

September 6, 2007

FDA approves the first generic versions of Coreg (carvedilol). FDA News
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01695.html

FDA approves Somatuline Depot (lanreotide acetate injection) for the
treatment of acromegaly. FDA News
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01692.html

New and Generic Drug Approvals
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm

Amlodipine Besylate Tablets, Actavis, Approval

Carvedilol Tablets, Actavis Elizabeth, Approval

Carvedilol Tablets, Apotex Corp., Approval

Carvedilol Tablets, Caraco Pharma, Approval

Carvedilol Tablets, Dr. Reddy's Labs, Approval

Carvedilol Tablets, Mylan Pharma, Approval

Carvedilol Tablets, Ranbaxy, Approval

Carvedilol Tablets, Sandoz Inc., Approval

Carvedilol Tablets, Taro Pharma, Approval

Carvedilol Tablets, Teva Pharma, Approval

Carvedilol Tablets, Watson Labs, Approval

Carvedilol Tablets, Zydus Pharma, Approval

Ciclopirox Topical Solution, Watson Labs, Tentative Approval

Clarithromycin Oral Suspension, Sandoz Inc., Approval

Differin (adapalene) Gel, Galderma Labs, Manufacturing Change or
Addition

Duetact (pioglitazone HCl + glimepiride) Fixed-dose Combination Tablets,
Takeda Global, Package Change

Hydrochlorothiazide Tablets, Cadista Pharma, Approval

MDP Multidose Utilipak (Technetium Tc99m Medronate) Injection, GE
HealthCare, Labeling Revision

Mucinex (guaifenesin) Extended Release Bi-layer Tablets, Adams
Respiratory Therapeutics, Formulation Revision

Mucinex D (guaifenesin, pseudoephedrine HCl and 1200 mg guaifenesin/120
mg pseudoephedrine HCl) Extended Release Bi-layer Tablets, Adams
Respiratory Therapeutics, Formulation Revision

Mucinex DM (guaifenesin, dextromethorphan HBr and guaifenesin
dextromethorphan HBr) Extended Release Bi-layer Tablets, Adams
Respiratory Therapeutics, Formulation Revision

Ofloxacin Otic Solution, Alcon, Tentative Approval

Omniscan Injection, GE HealthCare, Labeling Revision

------------------------------------------------
To subscribe or to unsubscribe from CDERNEW-TEXT

http://list.nih.gov/archives/cdernew-text.html
------------------------------------------------

posted by Mags @ 3:55 PM,




0 Comments:

Post a Comment

<< Home